InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Tari Leslie, Directeur Scientifique. Insider active across 1 company, notably Cidara Therapeutics, Inc.. Cumulatively, 13 disclosures have been logged. Breakdown: 1 buy · 7 sells. Total volume traded: €120k. Activity tracked since 30 September 2021. The latest transaction was disclosed on 11 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Tari Leslie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
1,773 shares@ US$21.962630.0% of flowCommon StockSEC:0001610618-25-000023:0
909 shares@ US$11.63938.0% of flowCommon StockSEC:0001610618-24-000123:0
111,250 shares0Common StockSEC:0001610618-24-000025:0
21,029 shares@ US$0.669810.7% of flowCommon StockSEC:0001610618-24-000016:0
18,469 shares@ US$0.94813.6% of flowCommon StockSEC:0001610618-23-000090:0
10,000 shares@ US$0.977.4% of flowCommon StockSEC:0001610618-23-000083:0
Canonical exit: 12 Nov 2023 (T+90)
90,000 shares0Common StockSEC:0001610618-23-000030:0
7,562 shares@ US$1.539.0% of flowCommon StockSEC:0001610618-23-000012:0
11,814 shares@ US$1.2011.0% of flowCommon StockSEC:0001610618-23-000003:0
18,159 shares@ US$0.684910.2% of flowCommon StockSEC:0001610618-22-000078:0
52,500 shares0Common StockSEC:0001610618-22-000021:0
2,101 shares0Common StockSEC:0001209191-22-002600:0
148,000 shares0Common StockSEC:0001610618-21-000089:0
13 of 13 declarations
About Tari Leslie
Tari Leslie is Chief Scientific Officer at Cidara Therapeutics, Inc. Across 13 total filings, the 13 sampled filings, from 2021-10-04 to 2025-03-13, show buy transactions of EUR 8891 and sell transactions of EUR 110967, with Cession as the modal transaction nature.
